Mr. Peter Bakema reports

CVR MEDICAL ANNOUNCES PROPOSED FINANCING

CVR Medical Corp. has arranged a private placement financing for gross proceeds of up to $1-million, which is expected to consist of units, with each unit comprising one common share and one-half of one common share purchase warrant at a price of 40 cents per unit, or such other price per unit determined by CVR Medical management in compliance with TSX Venture Exchange pricing regulations. Each whole purchase warrant will be exercisable to acquire one common share of CVR Medical at a price of 70 cents per share for a period of 12 months following the closing of the financing.

The financing is non-brokered. CVR Medical intends to pay finders' fees of up to 6 per cent in cash and 6 per cent in warrants in connection with the financing. Proceeds from the financing are expected to be used for continuing working capital requirements relating to the joint venture described below, specifically in regard to Food and Drug Administration applications and clinical trials.

Completion of the financing is subject to exchange acceptance, and all securities issued pursuant to the financing will be subject to a hold period of four months as required under applicable securities legislation. The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

For additional information on the organization and leadership, and current news, please visit the company's website.

About CVR Medical Corp.

CVR Medical is a company that is involved in an equal-part joint venture with CVR Global Inc. The joint venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic and low-frequency sound wave analysis technology, and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team.

We seek Safe Harbor.